BioPharm International
August 02, 2020
Cover Story
33
8
New therapeutics modalities and the need for greater process efficiency are driving technology development.
August 02, 2020
Quality/Regulations
33
8
This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
August 02, 2020
Development
33
8
Many antibody-drug conjugate therapies are in the pipeline; only a handful have been approved. What are the bottlenecks?
August 02, 2020
Upstream Processing
33
8
Process modeling offers an opportunity to troubleshoot for and anticipate difficult aspects of a bioprocess.
August 01, 2020
Downstream Processing
33
8
It is critical to evaluate specific considerations, from design to application, for the benefit of downstream bioprocessing and manufacturing.
August 01, 2020
Downstream Processing
33
8
Filling and packaging of primary containers is a crucial piece of COVID-19 vaccine production.
August 01, 2020
Manufacturing
33
8
Technologies in use and on the horizon could change aseptic processing in ways that seemed inconceivable years ago but approaches to aseptic process validation still need to move beyond their 1970s roots.
August 01, 2020
Analytics
33
8
Data from migration kinetics studies can be used to develop models that predict levels of leachables and extractables at different temperatures and time points.
August 01, 2020
Operations
33
8
Efforts are already underway to harmonize standards and regulatory approaches for testing of raw and ancillary materials, but continuous improvement is required.
August 01, 2020
Regulatory Beat
33
8
Efforts by regulators seek common approaches to clinical research and biopharmaceutical production needed to wipe out the coronavirus pandemic globally.
August 01, 2020
From the Editor
33
8
Time sure flies, except when you are waiting for something to happen.
August 01, 2020
Ask The Expert
33
8
When in-person training may not be feasible, there are still opportunities to ensure employees receive the required training, says Susan J. Schniepp, distinguished fellow, Regulatory Compliance Associates.